PM577a
Asset
Prime editing therapy to correct the H1069Q mutation in ATP7B
- Stage
- Phase 1
- Modality
- Gene editing
- Target
- DNA repair
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Wilson disease
Phase 1, globenewswire.com, 5 Oct 2026
In the full profile
- Targets and what it contains2
- Owner and partners1
- Evidence for its targets2
- Competitors9
- Aging relevance1
Every asset’s record: target, stage, trials and the evidence behind it.